01 12BDSI
02 2EMERGENT
03 2HARM REDUCTION THERP
04 5HIKMA
05 16INDIVIOR
06 84KALEO INC
07 52OREXO US INC
08 6PURDUE PHARMA LP
09 4ZMI PHARMA
01 27731686
02 37731690
03 27749194
04 27918823
05 37947017
06 38016788
07 28021344
08 38147866
09 28206360
10 28226610
11 28231573
12 38313466
13 38361029
14 38425462
15 68470361
16 48475832
17 48603514
18 38608698
19 28627816
20 68658198
21 38703177
22 28926594
23 38939943
24 68940330
25 39022022
26 29056170
27 39073933
28 29238108
29 69259421
30 29278182
31 69439900
32 39474869
33 19480644
34 29517307
35 39522188
36 39522919
37 39655843
38 49687454
39 19707226
40 29724471
41 39737669
42 19814838
43 210143792
44 110143972
45 210220158
46 310314977
47 310322239
48 310335549
49 110722510
50 310737028
51 110874661
52 610946010
53 210960155
54 110973814
55 111020343
56 411020387
57 611020388
58 111027072
59 111135155
60 411135216
61 511433066
62 311571518
63 311590286
64 111617713
65 111628139
66 111806428
01 6Y
02 177Blank
01 168Y
02 15Blank
01 42024-04-03
02 252024-11-23
03 32025-01-15
04 32025-03-21
05 62025-03-30
06 32025-04-30
07 22026-02-01
08 22026-03-31
09 12026-06-01
10 12026-06-10
11 22026-06-25
12 32026-12-12
13 22027-02-20
14 22027-02-27
15 22027-05-23
16 62027-07-23
17 62027-12-03
18 32028-03-12
19 22028-10-30
20 22028-11-25
21 22029-04-10
22 82029-08-07
23 22029-11-02
24 42030-03-26
25 62030-05-22
26 132031-02-28
27 32031-05-24
28 22032-02-04
29 22032-05-11
30 32032-08-20
31 402032-09-18
32 22034-07-18
33 52034-08-26
34 22035-03-16
35 22035-03-20
36 32035-04-24
37 12039-05-24
38 32041-06-14
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9655843
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-2017
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2027-07-23
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8147866
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code : U-1521
Delist Requested :
Patent Use Description : MAINTENANCE TREATMENT ...
Patent Expiration Date : 2027-07-23
Patent Expiration Date : 2035-04-24
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9522188
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-24
Patent Expiration Date : 2032-08-20
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8703177
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-20
Patent Expiration Date : 2035-04-24
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 9522188
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2035-04-24
Patent Expiration Date : 2032-08-20
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE
US Patent Number : 8703177
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205637
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-20
LOOKING FOR A SUPPLIER?
